Effect of herbal medicine Saiko-Keishi-To (TJ-10) on rat spontaneous chronic pancreatitis: Comparison with other herbal medicines

International Journal of Pancreatology

Volumn 27, Issue 2, 2000, Pages 123-129

  Motoo, Yoshiharu ^a   Su, Shi Bing ^a   Xie, Min Jue ^a   Taga, Hiromi ^a   Sawabu, Norio ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Chronic pancreatitis; Gene expression; Herbal medicine; Pancreatitis associated protein (PAP); Saiko keishi to (TJ 10); WBN Kob rat

Indexed keywords

ACUTE PHASE PROTEIN; CAMOSTAT; HANGE SHASHIN TO; HERBACEOUS AGENT; SHOSAIKOTO GO KEISHIKASHAKUYAKUTO; TJ 102; TJ 107; TJ 24; TJ 43; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC PANCREATITIS; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENCY; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; MALE; NONHUMAN; PHYTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ACUTE-PHASE PROTEINS; ANIMALS; ANTIGENS, NEOPLASM; CHRONIC DISEASE; DRUGS, CHINESE HERBAL; GENE EXPRESSION; LECTINS, C-TYPE; MALE; PANCREATITIS; RATS; RATS, INBRED STRAINS; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 0034130094     PISSN: 01694197     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. 1 Lankisch PG and Banks PA. Chronic pancreatitis: pathology, in Pancreatitis (Lankisch PG and Banks PA, eds.), Springer-Verlag, Berlin 1998; pp. 215-218.
2. 2 Mori Y, Yokoyama J, Nishimura M, Serizawa O, Ikeda Y. Effect of camostat on pancreatic impairment in WBN/Kob rats. Biomed Res 1989; 10(Suppl 1): 157-166.
3. 3 Otsuki M, Tani S, Okabayashi Y, Fuji M, Nakamura T, Fujisawa T, Itoh H. Beneficial effects of the synthetic trypsin inhibitor camostate in cerulein-induced acute pancreatitis in rats. Dig Dis Sci 1990; 35: 242-250.
4. 4 Sugiyama M, Kobori O, Atomi Y, Wada N, Kuroda A, Muto T. Effect of oral administration of protease inhibitor on pancreatic exocrine function in WBN/Kob rats with chronic pancreatitis. Pancreas 1996; 13: 71-79.
5. 5 Nakata K, Hosono Y, Hosono H, Sakaguchi H, Hosono S. The treatment with Kampo medicine for chronic pancreatitis. Jpn J Orient Med 1986; 36: 25-43 (in Japanese with English abstract).
6. 6 Wakasugi H. Kampo treatment of chronic pancreatitis. J Clin Exp Med 1993; 67: 824-829 (in Japanese).
7. 7 Su S-B, Motoo Y, Xie M-J, Sakai J, Taga H, Sawabu N. Expression of pancreatitis-associated protein (PAP) in spontaneous chronic pancreatitis in the WBN/Kob rat: effect of herbal medicine Saiko-keishi-to (TJ-10). Pancreas 1999; 19: 239-247.
8. 8 Ohashi K, Kim JH, Hara H, Aso R, Akimoto T, Narama K. WBN/Kob rats, a new spontaneously occurring model of chronic pancreatitis. Int J Pancreatol 1990; 6: 231-247.
9. 9 Arai I, Hasegawa M, Mase A, Kitani T, Komatsu Y, Yamaura H, et al. Development of pancreatic dysfunction and pathohistology in WBN/Kob rats using special breeding diet. Jpn J Appl Physiol 1997; 27: 373-380.
10. 10 Itoh T, Teraoka H. Cloning and tissue-specific expression of cDNAs for the human and mouse homologues of rat pancreatitis-associated protein (PAP). Biochem Biophys Acta 1993; 1172: 184-186.
11. 11 Keim V, Iovanna JL, Dagorn J-C. The acute phase reaction of the exocrine pancreas: gene expression and synthesis of pancreatitis-associated proteins. Digestion 1994; 55: 65-72.
12. 12 Iovanna JL, Keim V, Nordback I, et al. Serum levels of pancreatitis-associated protein as indicators of the course of acute pancreatitis. Gastroenterology 1994; 106: 728-734.
13. 13 Motoo Y, Satomura Y, Mouri I, et al. Serum levels of pancreatitis-associated protein in digestive diseases with special reference to gastrointestinal cancers. Dig Dis Sci 1999; 44: 1142-1147.
14. 14 Sparmann G, Merkord J, Jaschke A, et al. Pancreatic fibrosis in experimental pancreatitis induced by dibutyltin dichloride. Gastroenterology 1997; 112: 1664-1672.
15. 15 Kataoka K, Sasaki T, Yorizumi H, Sakagami J, Kashima K. Pathophysiologic studies of experimental chronic pancreatitis in rats induced by injection of zein-oleic acidlinoleic acid solution into the pancreatic duct. Pancreas 1998; 16: 289-299.
16. 16 Yamamoto M, Kumagai A, Yamamura Y. Structure and actions of saikosaponins isolated from Bupleurum falcatum L. I. Anti-inflammatory action of saikosaponins. Arzneimittelforschung 1975; 25: 1021-1023.
17. 17 Zhou ZC, Wang GZ, Ma JL. The anti-allergic inflammation action of saikosaponins. J Tradit Chin Med 1983; 3: 103-112.
18. 18 Shiratori K, Watanabe S, Takeuchi T. Effect of licorice extract (Fm 100) on release of secretin and exocrine pancreatic secretion in humans. Pancreas 1986; 1: 483-487.
19. 19 Takahashi S, Yoshikawa T, Naito Y, Minamiyama Y, Tanigawa T, Kondo M. Antioxidant properties of anti-ulcer Kampo medicines. Free Radic Res Commun 1993; 19(Suppl 1): S101-S108.
20. 2 extracted from a medicinal plant, Panax ginseng. J Biol Chem 1996; 271: 24,539-24,543.
21. 1). Am J Chin Med 1995; 23: 279-287.
22. +-ATPase purified from hog stomach. Clin Gastroenterol (Tokyo) 1997; 12: 1185-1188 (in Japanese with English abstract).
23. 23 Mori K, Marugami Y, Suganuma M, Shikata A, Ochiai M, Funabiki T. Inhibitory effect of omeprazole on caerulein-induced pancreatitis: comparison with the effect of nafamostat mesilate. J Jpn Panc Soc 1995; 10: 345-350(in Japanese with English abstract).